An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia
Clinical trial NCT01245530 · COMPLETED
Trial details
- NCT number
- NCT01245530
- Sponsor
- Whanin Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-02-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.